Health Policy
Good policy needs good information. The Health Policy Division’s purpose is to provide comprehensive and accurate information so that governments and other bodies can make better policy decisions and allocate funds more effectively.
The division covers international public health with a strong focus on product development for the ‘neglected diseases’ of developing countries, such as malaria, sleeping sickness and tuberculosis.
Key Strategies
Governments are keen to support research and development (R&D) of drugs, vaccines and diagnostics for ‘neglected diseases’, however they have limited information on how much is needed, where it should be spent and which approaches do - and don't - work. This has led to reluctance to provide funding for some, and to sub-optimal public R&D investment strategies and policies by others.
The Health Policy Division aims to address these problems by:
- Generating and gathering accurate information on product development, pipelines, incentives, strategies and outcomes for neglected diseases in developing countries
- Providing information and analysis to governments and philanthropic organisations to influence policy-making and funds allocation
Dr Mary Moran is the Director of the Health Policy Division.